Viewing Study NCT04984356


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-22 @ 4:14 PM
Study NCT ID: NCT04984356
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2021-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL
Sponsor: Wugen, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-cell Acute Lymphoblastic Leukemia View
None Lymphoblastic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR-T therapy View